Patient-Reported Outcomes From Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine

doi 10.25251/skin.2.supp.41

Full Text

Abstract

Available in

Date

February 23, 2018

Authors

Publisher

National Society for Cutaneous Medicine

Related search

Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial

British Journal of Haematology

Hematology

2018

English

Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes From Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)

SKIN The Journal of Cutaneous Medicine

2017

English

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Neurology

2015

English

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

English

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2019

English

Feasibility of Double-Blind Clinical Trials With Oral Diacetylmorphine: A Randomized Controlled Phase II Study in an Inpatient Setting

European Addiction Research

English

Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Journal of Allergy and Clinical Immunology

Allergy

Immunology

2018

English

Axillary Hyperhidrosis.

BMJ

1978

English

Atmospheric Trace Molecule Spectroscopy (ATMOS) Experiment Version 3 Data Retrievals

Applied Optics

2002

English

Amanote Research

Patient-Reported Outcomes From Two Randomized, Double-Blind, Vehicle Controlled Phase 3 Trials in Axillary Hyperhidrosis (ATMOS-1 & ATMOS-2)

SKIN The Journal of Cutaneous Medicine

Full Text

Abstract

Date

Authors

Publisher

Related search

Patient-Reported Outcomes of Multiple Myeloma Patients Treated With Panobinostat After ≥2 Lines of Therapy Based on the International Phase 3, Randomized, Double-Blind, Placebo-Controlled PANORAMA-1 Trial

Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes From Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2)

Etanercept in Alzheimer Disease: A Randomized, Placebo-Controlled, Double-Blind, Phase 2 Trial

Impact of Tocilizumab Monotherapy on Patient-Reported Outcomes in Patients With Rheumatoid Arthritis From Two Randomised Controlled Trials

Prevalence of Comorbidities With Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Feasibility of Double-Blind Clinical Trials With Oral Diacetylmorphine: A Randomized Controlled Phase II Study in an Inpatient Setting

Efficacy and Safety of AR101 in Peanut Allergy: Results From a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial (PALISADE)

Axillary Hyperhidrosis.

Atmospheric Trace Molecule Spectroscopy (ATMOS) Experiment Version 3 Data Retrievals